Document Detail


Open maintenance treatment of bipolar disorder spectrum patients who responded to gabapentin augmentation in the acute phase of treatment.
MedLine Citation:
PMID:  10628894     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
This report describes the results of maintenance treatment with gabapentin in 18 previously refractory Bipolar Disorder patients who initially responded to augmentation with gabapentin during the acute phase of their therapy. Seven of the original 18 patients (39%) have continued to experience benefit from maintenance gabapentin treatment. Only three patients had to discontinue the gabapentin because of side effects. None of the 18 patients experienced an obvious significant adverse drug-drug interaction. Five of the patients discontinued gabapentin because of diminished clinical efficacy after a significant period of positive therapeutic effect. The results of this small open study suggest that gabapentin may be effective as an augmenting agent in the maintenance phase of treatment of some bipolar spectrum patients.
Authors:
C B Schaffer; L C Schaffer
Related Documents :
8093824 - A controlled nordic multicentre study of zuclopenthixol acetate in oil solution, halope...
22031514 - Detection of 3-iodothyronamine in human patients: a preliminary study.
16850754 - Neuron-specific enolase and myelin basic protein in cerebrospinal fluid of patients wit...
22899764 - Macular pigment parameters in patients with macular telangiectasia (mactel) and normal ...
2487384 - Long term results (greater than 5 years) in patients with peritoneovenous shunting for ...
12468814 - Clinical and serological associations of ribosomal p autoantibodies in systemic lupus e...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of affective disorders     Volume:  55     ISSN:  0165-0327     ISO Abbreviation:  J Affect Disord     Publication Date:  1999 Oct 
Date Detail:
Created Date:  2000-04-21     Completed Date:  2000-04-21     Revised Date:  2013-06-11    
Medline Journal Info:
Nlm Unique ID:  7906073     Medline TA:  J Affect Disord     Country:  NETHERLANDS    
Other Details:
Languages:  eng     Pagination:  237-40     Citation Subset:  IM    
Affiliation:
Department of Psychiatry, UC Davis School of Medicine, Sacramento, CA 95816, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acetates / adverse effects,  pharmacology,  therapeutic use*
Acute Disease
Adult
Amines*
Antimanic Agents / adverse effects,  pharmacology,  therapeutic use*
Bipolar Disorder / drug therapy*,  psychology
Cyclohexanecarboxylic Acids*
Female
Follow-Up Studies
Humans
Male
Middle Aged
Recurrence
Treatment Outcome
gamma-Aminobutyric Acid*
Chemical
Reg. No./Substance:
0/Acetates; 0/Amines; 0/Antimanic Agents; 0/Cyclohexanecarboxylic Acids; 56-12-2/gamma-Aminobutyric Acid; 6CW7F3G59X/gabapentin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The effect of treatment with a new antidepressant, INN 00835, on platelet serotonin uptake in depres...
Next Document:  A preliminary communication of an insight scale in the assessment of lithium non-adherence among Chi...